Skip to main content
. Author manuscript; available in PMC: 2012 Nov 15.
Published in final edited form as: J Immunol. 2011 Oct 17;187(10):4987–4997. doi: 10.4049/jimmunol.1102173

Figure 1. Ebi3−/−Il10−/− Tregs are suppressive in vitro and in vivo.

Figure 1

(A) Wild type or knock out Treg purified by FACS were titrated in a standard Treg assay with Tconv cells and anti-CD3 and anti-CD28 coated latex beads. Proliferation of Tconv responder cells was determined by [3H]-thymidine incorporation (p-value: wild type Tregs compared to Ebi3−/−Il10−/−, and Il12a−/−Il10−/− Tregs, Not significant (NS)). (B) Wild type or knock out Treg were cultured with anti-CD3 and anti-CD28 coated latex beads and Tconv cells in the inserts of a Transwell™ culture plate. Third party, wild type responder Tconv was activated in the bottom chamber of the plate. Proliferation of responder cells was determined by [3H]-thymidine incorporation. Proliferation ranged from 30,000–60,000 cpm. p-value: *: <0.05, NS: Not significant. (C) Congenically marked wild type Tconv cells, wild type or knock out Tregs purified by FACS were injected at 4:1 ratio into Rag1−/− mice. CD4+ cell numbers in the spleen were analyzed after 7 days by flow cytometry. p-value: * <0.05. (D) Wild type Tconv cells (0.5×106) were injected into Rag1−/− mice. The weight of the mice was monitored weekly for weight loss. Once the mice had lost 5% of its body weight wild type or knock out Tregs were injected. Mice were monitored for percent weight change calculated based on the weight at the time of Treg injection. p-value: * <0.05 and NS: Not significant. (E) Colonic tissue sections stained with H & E stain were scored in a blinded manner. Representative images of sections from 3 independent experiments are shown with histological score in parentheses. Data represent the mean ± SEM of (A) 3, (B) 3–5, (C) 4–9 mice per group, (D&E) 3 independent experiments.

HHS Vulnerability Disclosure